Intuitive Surgical (ISRG, Financials) reported fourth-quarter revenue of $2.41 billion on Thursday, a 25% year-over-year increase, with earnings per share of $2.21 surpassing analysts' expectations by $0.42.
The company's shares dropped 2.21% to $595.20 in after-hours trading at 7:59 p.m. EST after the news, however.
Rising from $574 million in the previous year, non-GAAP net income increased to $805 million. Including 174 of its newest da Vinci 5 models, the business placed 493 da Vinci surgical systems during the quarter, thereby increasing the worldwide installed base to 9,902 systems, a 15% year-over-year growth.
Reflecting an 18% rise in da Vinci procedure volumes and a 70% jump in Ion system procedures, revenue from instruments and accessories grew 23% to $1.41 billion. Supported by better average selling prices and fewer leased systems, system income climbed to $655 million, a 37% year-over-year increase.
Comparing GAAP operating profits to $450 million year ago, it surged to $735 million. Operating income non- GAAP climbed to $928 million. Operating cash flow drove the corporation to close the quarter with $8.83 billion in cash.
Looking forward, Intuitive projects 13% to 16% increase in global da Vinci operations by 2025. From 69.1% in 2024, non-GAAP gross profit margins are expected to fluctuate between 67% and 68%, down from here depending on any effects from additional tariffs.
This article first appeared on GuruFocus.免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。